Detalhe da pesquisa
1.
Does discovery of differentially culturable M tuberculosis really demand a new treatment paradigm? Longitudinal analysis of DNA clearance from sputum.
BMC Infect Dis
; 18(1): 293, 2018 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29970012
2.
Acquisition of Rifampin Resistance in Pulmonary Tuberculosis.
Antimicrob Agents Chemother
; 61(4)2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28167550
3.
Direct comparison of Xpert MTB/RIF assay with liquid and solid mycobacterial culture for quantification of early bactericidal activity.
J Clin Microbiol
; 51(6): 1894-8, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23596237
4.
Suitability of Xpert MTB/RIF and genotype MTBDRplus for patient selection for a tuberculosis clinical trial.
J Clin Microbiol
; 49(8): 2827-31, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21653771
5.
Propidium monoazide and Xpert MTB/RIF to quantify Mycobacterium tuberculosis cells.
Tuberculosis (Edinb)
; 101: 79-84, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27865403
6.
Simultaneous staining of sputum smears for acid-fast and lipid-containing Myobacterium tuberculosis can enhance the clinical evaluation of antituberculosis treatments.
Tuberculosis (Edinb)
; 95(6): 770-779, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26318558
7.
The evaluation of anti-tuberculosis drug effects on phenotypes of Mycobacterium tuberculosis not detected by culture methods.
Tuberculosis (Edinb)
; 116: 32-34, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31153515